Rating History for Sagimet Biosciences Inc (SGMT) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/9/2026 | Eliana Merle | Upgrade | Overweight (Equalweight) |
18.00 (8.00) |
10.94 (11.06) |
1.1% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/9/2026 | Eliana Merle | Upgrade | Overweight (Equalweight) |
18.00 (8.00) |
10.94 (11.06) |
1.1% | Details |
![]() |
|||||||